Herceptin (trastuzumab), Herceptin Hylecta (trastuzumab and hyaluronidase-oysk), Hercessi (trastuzumab-strf), Kanjinti (trastuzumab-anns), Ontruzant (trastuzumab-dttb), and Trazimera (trastuzumab-qyyp) are more costly to Aetna than other Anti-HER2 Monoclonal Antibodies. There is a lack of relia...
Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) is a combination of a HER2/neu receptor antagonist, and an endoglycosidase, indicated in adults for the treatment of HER2-overexpressing breast cancer. What Are Side Effects of Herceptin Hylecta? Herceptin Hylecta may cause serious side effects in...
Herceptin HYLECTA (trastuzumab and hyaluronidase-oysk) is approved for the treatment of adults with early-stage breast cancer that isHumanEpidermal growth factorReceptor2-positive (HER2+) and has spread into the lymph nodes, or is HER2-positive and has not spread into the lymph nodes. If it ...